D. Yancopoulos George's Insider Trades & SAST Disclosures

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Gift of securities by or to the insider at price $ 0.00 per share.	10 Jun 2024	75,799	0 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Gift of securities by or to the insider at price $ 0.00 per share.	10 Jun 2024	37,900	56,048 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 969.39 per share.	16 May 2024	9,501	822,762 (0%)	0%	969.4	9,210,174	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 975.48 per share.	16 May 2024	9,242	792,875 (0%)	0%	975.5	9,015,386	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 974.51 per share.	16 May 2024	7,611	802,117 (0%)	0%	974.5	7,416,996	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 971.56 per share.	16 May 2024	4,922	813,171 (0%)	0%	971.6	4,782,018	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 976.52 per share.	16 May 2024	4,886	787,989 (0%)	0%	976.5	4,771,277	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 970.26 per share.	16 May 2024	4,669	818,093 (0%)	0%	970.3	4,530,144	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 968.44 per share.	16 May 2024	3,213	832,263 (0%)	0%	968.4	3,111,598	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 973.80 per share.	16 May 2024	2,653	809,728 (0%)	0%	973.8	2,583,491	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 977.38 per share.	16 May 2024	1,227	786,762 (0%)	0%	977.4	1,199,245	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 967.40 per share.	16 May 2024	907	835,476 (0%)	0%	967.4	877,432	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 972.22 per share.	16 May 2024	790	812,381 (0%)	0%	972.2	768,054	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 978.18 per share.	16 May 2024	379	786,383 (0%)	0%	978.2	370,730	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 977.42 per share.	15 May 2024	9,851	848,105 (0%)	0%	977.4	9,628,564	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 976.56 per share.	15 May 2024	6,885	857,956 (0%)	0%	976.6	6,723,616	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 975.60 per share.	15 May 2024	5,225	864,841 (0%)	0%	975.6	5,097,510	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 978.44 per share.	15 May 2024	4,865	843,240 (0%)	0%	978.4	4,760,111	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 974.47 per share.	15 May 2024	4,778	870,066 (0%)	0%	974.5	4,656,018	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 968.43 per share.	15 May 2024	3,387	880,675 (0%)	0%	968.4	3,280,072	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 981.52 per share.	15 May 2024	2,283	839,230 (0%)	0%	981.5	2,240,810	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 969.14 per share.	15 May 2024	1,930	878,745 (0%)	0%	969.1	1,870,440	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 973.43 per share.	15 May 2024	1,865	874,844 (0%)	0%	973.4	1,815,447	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 967.45 per share.	15 May 2024	1,428	884,062 (0%)	0%	967.5	1,381,519	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 980.72 per share.	15 May 2024	1,223	841,513 (0%)	0%	980.7	1,199,421	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 970.36 per share.	15 May 2024	846	877,899 (0%)	0%	970.4	820,925	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 972.50 per share.	15 May 2024	784	876,709 (0%)	0%	972.5	762,440	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 966.29 per share.	15 May 2024	782	885,490 (0%)	0%	966.3	755,639	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 983.88 per share.	15 May 2024	727	838,200 (0%)	0%	983.9	715,281	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 985.62 per share.	15 May 2024	647	837,500 (0%)	0%	985.6	637,696	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 979.87 per share.	15 May 2024	504	842,736 (0%)	0%	979.9	493,854	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 986.40 per share.	15 May 2024	442	837,058 (0%)	0%	986.4	435,989	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 971.28 per share.	15 May 2024	406	877,493 (0%)	0%	971.3	394,340	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 988.36 per share.	15 May 2024	373	836,503 (0%)	0%	988.4	368,658	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 982.29 per share.	15 May 2024	303	838,927 (0%)	0%	982.3	297,634	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 987.38 per share.	15 May 2024	182	836,876 (0%)	0%	987.4	179,703	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 989.14 per share.	15 May 2024	120	836,383 (0%)	0%	989.1	118,697	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 965.69 per share.	15 May 2024	111	886,272 (0%)	0%	965.7	107,192	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 984.02 per share.	15 May 2024	53	838,147 (0%)	0%	984.0	52,153	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Gift of securities by or to the insider at price $ 0.00 per share.	29 Apr 2024	36,296	0 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Gift of securities by or to the insider at price $ 0.00 per share.	29 Apr 2024	18,148	18,148 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	George Yancopoulos D.	Director, Bd. Co-Chair, President & CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Feb 2024	172,723	0	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Yancopoulos George D.	Director, Bd. Co-Chair, President & CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 399.66 per share.	15 Feb 2024	172,723	925,209 (0%)	0%	399.7	69,030,474	Common Stock
Regeneron Pharmaceuticals,...	D. Yancopoulos George	Director, Bd. Co-Chair, President & CSO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 953.83 per share.	15 Feb 2024	123,601	801,608 (0%)	0%	953.8	117,894,342	Common Stock
Regeneron Pharmaceuticals,...	D. George Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 900.00 per share.	02 Jan 2024	16,848	180,000 (0%)	0%	900	15,163,200	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, Bd. Co-Chair, President & CSO	Sale of securities on an exchange or to another person at price $ 900.00 per share.	02 Jan 2024	16,848	180,000 (0%)	0%	900	15,163,200	Common Stock
Regeneron Pharmaceuticals,...	D. George Yancopoulos	Director, Bd. Co-Chair, President & CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Dec 2023	25,155	765,327 (0%)	0%		-	Common Stock
Regeneron Pharmaceuticals,...	George Yancopoulos D.	Director, Bd. Co-Chair, President & CSO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Dec 2023	25,155	0	-		-	2019 Performance Stock Units
Regeneron Pharmaceuticals,...	Yancopoulos George D.	Director, Bd. Co-Chair, President & CSO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 844.09 per share.	11 Dec 2023	12,841	752,486 (0%)	0%	844.1	10,838,960	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 802.54 per share.	23 Mar 2023	1,237	198,891 (0%)	0%	802.5	992,742	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 806.47 per share.	23 Mar 2023	700	197,248 (0%)	0%	806.5	564,529	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 803.30 per share.	23 Mar 2023	642	198,249 (0%)	0%	803.3	515,719	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 810.30 per share.	23 Mar 2023	400	196,848 (0%)	0%	810.3	324,120	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 800.59 per share.	23 Mar 2023	254	200,250 (0%)	0%	800.6	203,350	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 804.38 per share.	23 Mar 2023	254	197,995 (0%)	0%	804.4	204,313	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 801.16 per share.	23 Mar 2023	122	200,128 (0%)	0%	801.2	97,742	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 805.55 per share.	23 Mar 2023	47	197,948 (0%)	0%	805.6	37,861	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 800.08 per share.	06 Feb 2023	13,189	200,504 (0%)	0%	800.1	10,552,255	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Dec 2021	239,063	0	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Exercise or conversion of derivative security received from the company (such as an option) at price $ 179.13 per share.	22 Dec 2021	239,063	1,126,546 (1%)	0%	179.1	42,823,355	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Exercise or conversion of derivative security received from the company (such as an option) at price $ 270.43 per share.	22 Dec 2021	203,204	1,169,835 (1%)	0%	270.4	54,952,458	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Dec 2021	203,204	0	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Payment of exercise price or tax liability using portion of securities received from the company at price $ 610.04 per share.	22 Dec 2021	159,915	966,631 (0%)	0%	610.0	97,554,547	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Payment of exercise price or tax liability using portion of securities received from the company at price $ 610.04 per share.	22 Dec 2021	150,182	1,019,653 (0%)	0%	610.0	91,617,027	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 625.25 per share.	13 Aug 2021	46,925	889,785 (0%)	0%	625.2	29,339,856	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 626.10 per share.	13 Aug 2021	2,302	887,483 (0%)	0%	626.1	1,441,282	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 625.00 per share.	13 Aug 2021	773	936,710 (0%)	0%	625	483,125	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Gift of securities by or to the insider at price $ 0.00 per share.	05 Aug 2021	211,585	0 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Gift of securities by or to the insider at price $ 0.00 per share.	05 Aug 2021	211,585	213,693 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 600.06 per share.	05 Aug 2021	50,000	937,483 (0%)	0%	600.1	30,003,000	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Gift of securities by or to the insider at price $ 0.00 per share.	21 Jun 2021	82,108	82,108 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 541.44 per share.	21 Jun 2021	19,911	14,898 (0%)	0%	541.4	10,780,612	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Gift of securities by or to the insider at price $ 0.00 per share.	21 Jun 2021	14,000	0	-		-	Class A Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Gift of securities by or to the insider at price $ 0.00 per share.	21 Jun 2021	14,000	14,000	-		-	Class A Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 542.43 per share.	21 Jun 2021	10,514	4,384 (0%)	0%	542.4	5,703,109	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 534.48 per share.	21 Jun 2021	8,236	65,640 (0%)	0%	534.5	4,401,977	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 540.61 per share.	21 Jun 2021	8,099	34,809 (0%)	0%	540.6	4,378,400	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 533.66 per share.	21 Jun 2021	7,494	73,876 (0%)	0%	533.7	3,999,248	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 537.61 per share.	21 Jun 2021	6,636	51,082 (0%)	0%	537.6	3,567,580	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Gift of securities by or to the insider at price $ 0.00 per share.	21 Jun 2021	5,383	5,383	-		-	Class A Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Gift of securities by or to the insider at price $ 0.00 per share.	21 Jun 2021	5,383	0	-		-	Class A Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 538.54 per share.	21 Jun 2021	4,868	46,214 (0%)	0%	538.5	2,621,613	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 535.63 per share.	21 Jun 2021	4,154	61,486 (0%)	0%	535.6	2,225,007	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 536.37 per share.	21 Jun 2021	3,768	57,718 (0%)	0%	536.4	2,021,042	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 539.66 per share.	21 Jun 2021	3,306	42,908 (0%)	0%	539.7	1,784,116	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 543.13 per share.	21 Jun 2021	2,276	2,108 (0%)	0%	543.1	1,236,164	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Sale of securities on an exchange or to another person at price $ 532.89 per share.	21 Jun 2021	738	81,370 (0%)	0%	532.9	393,273	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.03 per share.	30 Dec 2020	240,000	880,938 (0%)	0%	52.0	12,487,200	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Dec 2020	240,000	158,079	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.03 per share.	30 Dec 2020	158,079	908,303 (0%)	0%	52.0	8,224,850	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Dec 2020	158,079	0	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Payment of exercise price or tax liability using portion of securities received from the company at price $ 483.25 per share.	30 Dec 2020	130,714	750,224 (0%)	0%	483.3	63,167,541	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Payment of exercise price or tax liability using portion of securities received from the company at price $ 483.25 per share.	30 Dec 2020	86,096	822,207 (0%)	0%	483.3	41,605,892	Common Stock
Regeneron Pharmaceuticals,...	George D. Yancopoulos	Director, President and Chief Scientific	Gift of securities by or to the insider at price $ 0.00 per share.	30 Dec 2020	57,465	0 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades